Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely human chorionic gonadotropin 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely human chorionic gonadotropin 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oral spray |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oral spray |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Warfarin sodium 5 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Warfarin sodium 5 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
cefixim, vattenfritt (som cefixim) 40 milligram/milliliter, oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
cefixim, vattenfritt (som cefixim) 40 milligram/milliliter, oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely mucin 35 milligram/1 milliliter conventional release oral spray (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely mucin 35 milligram/1 milliliter conventional release oral spray (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 40 mg/mL oropharyngeal solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 40 mg/mL oropharyngeal solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Blood group antibody D 1136 unit/mL solution for injection |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Blood group antibody D 1136 unit/mL solution for injection |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Somatrem 10 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Somatrem 10 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
humant immunglobulin G 6 gram/injektionsflaska, frystorkat pulver till injicerbar lösning |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
humant immunglobulin G 6 gram/injektionsflaska, frystorkat pulver till injicerbar lösning |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
peginterferon alfa-2b 120 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
peginterferon alfa-2b 120 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
peginterferon alfa-2b 80 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
peginterferon alfa-2b 80 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
doxycyklinmonohydrat 100 milligram, munsönderfallande tablett |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
doxycyklinmonohydrat 100 milligram, munsönderfallande tablett |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Sodium cromoglicate 20 mg/actuation powder for inhalation |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Sodium cromoglicate 20 mg/actuation powder for inhalation |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Dinoprostone 10 mg prolonged-release vaginal pessary |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Dinoprostone 10 mg prolonged-release vaginal pessary |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Tobramycin (as tobramycin sulfate) 1.2 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 60 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 60 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Sulfasalazine 30 mg/mL rectal suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Sulfasalazine 30 mg/mL rectal suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Amoxicillin anhydrous (as amoxicillin) 775 mg prolonged-release oral tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Amoxicillin anhydrous (as amoxicillin) 775 mg prolonged-release oral tablet |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Amoxicillin anhydrous (as amoxicillin) 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Amoxicillin anhydrous (as amoxicillin) 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
Hexachlorophene 30 mg/mL cutaneous emulsion |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Hexachlorophene 30 mg/mL cutaneous emulsion |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
mitomycin 40 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
mitomycin 40 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
mitomycin 5 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
mitomycin 5 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Selenium sulfide 25 mg/mL cutaneous lotion |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Selenium sulfide 25 mg/mL cutaneous lotion |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |